Boston Scientific Corporation
NYSE:BSX
Sector
Location
Market Cap
USD 155.89 B
Share Price
USD 105.21
Avg Daily Volume
7,358,579
Change (1 day)
-0.79%
Change (1 year)
33.50%
Change (YTD)
17.79%
Boston Scientific Corporation Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2025: 5.26%
Boston Scientific Corporation Return on Assets (ROA) is 5.26% for the Trailing 12 Months (TTM) ending March 31, 2025, a 3.40% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
-
Boston Scientific Corporation Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2024 was 5.08%, a 82.44% change year over year.
-
Boston Scientific Corporation Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2023 was 2.79%, a 9.73% change year over year.
-
Boston Scientific Corporation Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2022 was 2.54%, a 309.91% change year over year.
-
Boston Scientific Corporation Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2021 was 0.62%, a -95.96% change year over year.
StockViz
Competitors
Roche Holding AG
USD 339.30
RO.SW
-2.14
-0.63%
Thermo Fisher Scientific Inc.
USD 483.76
TMO
-11.05
-2.23%
Becton, Dickinson and Company
USD 196.63
BDX
-2.57
-1.29%
Fresenius SE & Co. KGaA
USD 55.21
FRE.DE
+0.28
0.51%
Sartorius Stedim Biotech S.A.
USD 204.62
DIM.PA
-4.38
-2.10%
bioMérieux S.A.
USD 147.87
BIM.PA
-1.60
-1.07%
United Therapeutics Corporation
USD 310.66
UTHR
+4.18
1.36%
Medpace Holdings, Inc.
USD 453.34
MEDP
-12.38
-2.66%
Revvity, Inc.
USD 89.67
RVTY
-2.03
-2.21%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.37
4.62%
Exact Sciences Corporation
USD 46.68
EXAS
-0.32
-0.68%
Bio-Techne Corporation
USD 54.00
TECH
-0.33
-0.61%
Sysmex Corporation
USD 13.21
6869.T
-0.02
-0.14%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 7.32
002294.SZ
+0.18
2.54%
Guardant Health, Inc.
USD 61.28
GH
+2.78
4.75%
Key Data
| Date | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share |
|---|
Competitors
Roche Holding AG
USD 339.30
RO.SW
-2.14
-0.63%
Thermo Fisher Scientific Inc.
USD 483.76
TMO
-11.05
-2.23%
Becton, Dickinson and Company
USD 196.63
BDX
-2.57
-1.29%
Fresenius SE & Co. KGaA
USD 55.21
FRE.DE
+0.28
0.51%
Sartorius Stedim Biotech S.A.
USD 204.62
DIM.PA
-4.38
-2.10%
bioMérieux S.A.
USD 147.87
BIM.PA
-1.60
-1.07%
United Therapeutics Corporation
USD 310.66
UTHR
+4.18
1.36%
Medpace Holdings, Inc.
USD 453.34
MEDP
-12.38
-2.66%
Revvity, Inc.
USD 89.67
RVTY
-2.03
-2.21%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.37
4.62%
Exact Sciences Corporation
USD 46.68
EXAS
-0.32
-0.68%
Bio-Techne Corporation
USD 54.00
TECH
-0.33
-0.61%
Sysmex Corporation
USD 13.21
6869.T
-0.02
-0.14%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 7.32
002294.SZ
+0.18
2.54%
Guardant Health, Inc.
USD 61.28
GH
+2.78
4.75%